These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday.
Affymetrix Inc. (NASDAQ: AFFX) Cut to Sell at Goldman Sachs.
Anheuser-Busch InBev (NYSE: BUD) Raised to Buy at Soc-Gen.
Cree Inc. (NASDAQ: CREE) Started as Underperform at BofA/ML.
Dollar Tree, Inc. (NASDAQ: DLTR) Cut to Hold at Deutsche Bank.
The Finish Line Inc. (NASDAQ: FINL) Reiterated Buy with $25 target at Canaccord Genuity.
HomeAway, Inc. (NASDAQ: AWAY) Raised to Outperform at Raymond James.
IMAX Corporation (NASDAQ: IMAX) Started as Overweight at JPMorgan.
ITT Corporation (NYSE: ITT) Raised to Buy at Janney.
Lab Corp of America (NYSE: LH) Raised to Neutral at Goldman Sachs.
Life Technologies Corporation (NASDAQ: LIFE) Cut to Sell at Goldman Sachs.
Pandora Media, Inc. (NYSE: P) Raised to Outperform at Raymond James.
Phillips 66 (NYSE: PSX) Raised to Buy at Deutsche Bank.
Quest Diagnostics Inc. (NYSE: DGX) Raised to Neutral at Goldman Sachs.
Research in Motion Ltd. (NASDAQ: RIMM) Cut to Sell at Soc-Gen.
Tiffany & Co. (NYSE: TIF) Raised to Buy with $63 target at Canaccord Genuity.
The SPDR S&P 500 (NYSEMKT: SPY) is indirectly targeted by UBS because the firm has lowered its S&P 500 year-end price target to 1,375 from 1,475.
If you enjoyed the top analyst upgrades and downgrades, you can join our free email newsletter that includes analyst summaries each morning sent right to your inbox. We also cover top issues such as IPOs, special financial exclusives, mergers and more. Sign up in the box below.
JON C. OGG